M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
| Ad-hoc news
The Management Board of M1 Kliniken AG (ISIN: DE000A0STSQ8) resolved this evening, with the approval of the Supervisory Board, to prepare the transfer of the listing of the Company’s shares from the Open Market (Basic Board) to the Regulated Market (Prime Standard) of the Frankfurt Stock Exchange. Admission is planned for 2027 and is subject to the admission requirements being met.
The Management Board has also raised its target for a sustainable EBIT margin in the Beauty segment by 2029 from at least 20% to at least 25%. The segment’s revenue target of EUR 200 million to EUR 300 million by 2029 remains unchanged.
